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Background:  Epidural injections are performed utilizing 3 approaches in the lumbar spine: caudal, 
interlaminar, and transforaminal. The literature on the efficacy of epidural injections has been sporadic. There 
ar e few high-quality randomized trials performed under fluoroscopy in managing disc herniation that have a 
long-term follow-up and appropriate outcome parameters. There is also a lack of literature comparing the 
efficacy of these 3 approaches.
Methods: This manuscript analyzes data from 3 randomized controlled trials that assessed a total of 360 
patients with lumbar disc herniation. There were 120 patients per trial either receiving local anesthetic alone 
(60 patients) or local anesthetic with steroids (60 patients). 
Results:  Analysis showed similar efficacy for caudal, interlaminar, and transforaminal approaches in 
managing chronic pain and disability from disc herniation. The analysis of caudal epidural injections showed 
the potential superiority of steroids compared with local anesthetic alone a 2-year follow-up, based on the 
average relief per procedure. In the interlaminar group, results were somewhat superior for pain relief in the 
steroid group at 6 months and functional status at 12 months. Interlaminar epidurals provided improvement 
in a significantly higher proportion of patients. The proportion of patients nonresponsive to initial injections 
was also lower in the group for local anesthetic with steroid in the interlaminar trial.
Conclusions: The results of this assessment show significant improvement in patients suffering from chronic 
lumbar disc herniation with 3 lumbar epidural approaches with local anesthetic alone, or using steroids with 
long-term follow-up of up to 2 years, in a contemporary interventional pain management setting. (Korean J 
Pain  2015;  28:  11-21)
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INTRODUCTION
The 2002, the Spine Patient Outcomes Research Trial 
(SPORT) was designed to prospectively collect primary data 
from patients identified as potential surgical candidates di-
agnosed with lumbar intervertebral disc herniation along 
with spinal stenosis and degenerative spondylolisthesis [1]. 
In a subgroup analysis of the SPORT trial, Radcliff et al. 
[2] suggested that epidural steroid injections are  asso-
ciated with a surgical avoidance rate of 41%. The results 
of SPORT also showed that disc herniation was seen in 
38% of patients at L4-5 and 53% to 56% of patients at 
L5-S1 [3]. A majority of the discs in this assessment were 
extruded, ranging from 64% to 67%. Sequestered discs oc-
curred in only 7% or 8% of the sample; whereas protruding 
discs were 26% to 29%. This is the latest contribution to 
the voluminous literature from the past 80 years or so de-
voted to the diagnosis and management of disc herniation 
as first described by Mixter and Barr in 1934 [4]. As shown 
in the SPORT trial, all patients with lumbar disc herniation 
or radiculopathy do not require surgical intervention, and 
multiple studies have shown that surgery may be avoided 
with epidural injections , admittedly at the variable rate of 
41%-56% [2,5]. Consequently, multiple minimally invasive 
treatments, including epidural injections, are applied in ad-
dition to conservative management. 
Epidural injections are one of the most commonly per-
formed interventions for managing disc herniation [6-13]. 
Epidural injections are performed in the lumbar spine uti-
l i z i n g  3  d i f f e r e n t  a p p r o a c h e s :  c a u d a l ,  i n t e r l a m i n a r ,  a n d  
transforaminal. These 3 approaches utilize different tech-
ni qu es with certain a d v an ta ges and disa d v an tages, with 
potentially different outcomes based on the level of struc-
tural abnormalities [8-13]. The utilization of surgical and 
interventional techniques has been increasing rapidly with 
epidural  injections  showing  an  increase  of  130%  per 
100,000 fee-for-service Medicare recipients [6,7]. From 
2000 to 2011 lumbar interlaminar epidural injections in-
creased by 25% [7]. In contrast, the increase in trans-
foraminal epidural injections during this same period was 
almost 27 times higher at a rate of 665% when compared 
to both lumbar interlaminar and caudal epidural injections 
combined. Increases of utilization for other interventional 
techniques also have been higher, with a 331% increase for 
sacroiliac joint injections followed by a 308% increase for 
facet joint interventions, and a 544% increase for lumbar 
facet joint radiofrequency thermoneurolysis [7].
The  interlaminar  approach  is  considered  capable  of 
delivering the medication closest to the assumed site of 
pathology, but the transforaminal approach is considered 
the most target-specific modality requiring the smallest 
volume to reach the primary site of pathology. In contrast, 
caudal epidural injections require relatively large volumes 
and are associated with an alleged lack of specificity to 
the assumed site of pathology. Regardless, it is considered 
the safest and easiest approach, with minimal risk of in-
advertent dural puncture, and is the preferred modality in 
postsurgery syndrome [8-13]. 
All  3  epidural  injection  approaches  for  lumbar  disc 
herniation have been widely studied. Multiple systematic 
reviews and a number of randomized trials have been con-
ducted assessing the effectiveness of all 3 epidural in-
j e c t i o n  a p p r o a c h e s  [ 8 - 1 3 ] .  T h e  s y s t e m a t i c  r e v i e w s  h a v e 
provided highly variable results regarding the effectiveness 
of epidural injections for managing disc herniation [8-13]. 
Benyamin et al. [9] Parr et al. [10], and Manchikanti et al. 
[11,13] performed systematic reviews showing that multiple 
trials were performed with an inappropriate study design, 
a series of 3 epidural injections, and without fluoroscopy. 
Among the 3 epidural injection approaches, there were only 
8 trials of moderate or high quality. All of these trials were 
performed under fluoroscopic visualization [8,13]. Further-
more, one randomized, controlled trial in each category 
was published by one group of authors, reporting the re-
sults of 120 patients in each trial with a 2-year follow-up 
[14-16]. Significant improvement in pain relief and func-
tional status improvement of 50% or more was seen in 
76%, 72%, and 77% of caudal, interlaminar, and trans-
foraminal epidural injections respectively in responsive pa-
tients (at least 3 weeks of improvement with 2 initial pro-
cedures). The results showed the efficacy of epidural in-
jections for all patients at 62%, 65%, and 61% of caudal, 
interlaminar, and transforaminal groups respectively, with 
significant improvement at 24 months. A cost utility analy-
sis performed for caudal epidural injections for disc her-
niation showed a one-year quality-adjusted life year (QALY) 
of $2,206 [17]. 
The increasing prevalence of low back pain, coupled 
with the exponential increase of numerous modalities of 
management, increasing disability and soaring health care 
costs  [6-8,18-20],  epidural  injections  have  faced  sig-
nificant criticism over the years despite emerging evidence Manchikanti, et al / Comparison of Epidurals in Lumbar Disc Herniation 13
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[8-17]. Multiple trials of epidural injections by Manchikanti 
et al. [14-16,21-28] and a systematic review by Bicket et 
al. [29] have shown a lack of significant difference in out-
comes between local anesthetics alone or local anesthetics 
with steroids. 
Consequently, in this assessment we sought to eval-
uate the efficacy of 3 lumbar epidural injection approaches 
for managing chronic, intractable, persistent pain in the 
low back and lower extremities secondary to disc hernia-
tion  or  radiculitis  after  partial  or  nonresponsiveness  of 
conservative management. The evaluation is based on 3 
r a n d o m iz ed  t r i a l s w i t h a  2 - y ea r  f o ll o w - u p  a n d  i d e n t i c a l 
protocols [14-16].
MATERIALS  AND  METHODS
The 3 trials [14-16] utilized for this assessment were 
conducted  with  the  approval  of  the  institutional  review 
board (IRB) and were registered with the US Clinical Trial 
registry.  Their  assigned  numbers  were  NCT00370799, 
NCT00681447 and NCT01052571. All trials were random-
ized, double-blind, active control trials utilizing local anes-
thetic alone or local anesthetic with steroids. These trials 
were performed in a private interventional pain manage-
m e n t  p r a c t i c e ,  a  s p e c i a l t y  r e f e r r a l  c e n t e r  i n  t h e  U n i t e d 
States, by the same authors. The trials were conducted 
based  on  Consolidated  Standards  of  Reporting  Trials 
(CONSORT) guidance.
The trials and this analysis were conducted with in-
ternal resources. 
The descriptions of participating patients, pre-enroll-
ment evaluation, interventions, inclusion and exclusion cri-
teria, description of interventions, additional interventions, 
co-interventions, objectives, outcomes, sample size calcu-
lation, randomization, sequence generation, allocation con-
cealment, implementation, blinding and statistical methods 
were described in detail in the manuscripts [14-16].
1. Participants
All  participating  patients  were  recruited  from  those 
presenting at the practice for interventional pain manage-
ment services. 
2. Interventions
The protocol consisted of 2 groups with 60 patients 
randomized into each group in each trial. The interventions 
were performed with local anesthetic alone or local anes-
thetic with steroid. For caudal epidural injections, a total 
of 10 ml of solution (10 ml of 0.5% lidocaine or 9 ml of 
lidocaine with 1 ml of steroid) was injected; for lumbar in-
terlaminar epidural injections a total of 6 ml of solution (6 
ml of 0.5% lidocaine or 5 ml of lidocaine with 1 ml of ste-
roid) was injected; for lumbar transforaminal epidural in-
jections a total volume of 2 ml was injected (1.5 ml of 1% 
preservative-free lidocaine along with 0.5 ml of sodium 
chloride solution or 3 mg of betamethasone).
3. Inclusion/Exclusion criteria
Inclusion criteria included disc herniation or radiculitis 
in patients over 18 years of age with at least 6 months 
of function-limiting low back and lower extremity pain.
Exclusion  criteria  included  previous  lumbar  surgery, 
radiculitis  secondary  to  spinal  stenosis,  and  radiculitis 
without disc herniation.
4. Description of interventions
All procedures were performed in a sterile operating 
room under fluoroscopy by one physician (LM) with appro-
priate monitoring and intravenous sedation as indicated. 
Caudal epidurals were performed by entering the epi-
dural space through the sacral hiatus and confirmed by 
c o n t r a s t  m ed i u m  in j ec t i o n . L u m ba r  i n t e r l a m in a r  e p i d u r a l 
i n j e c t i o n s  w e r e  p e r f o r m e d  w i t h  t h e  l o s s  o f  r e s i s t a n c e  
technique. All transforaminal epidural injections were per-
formed by entering the foramen at one or 2 levels at the 
inferior aspect of the foramina at the lumbar levels and 
the sa cr a l f or am ina with a 22-gauge Be ll a-D
Ⓡ-Coude
Ⓡ 
needle  (Epimed  International,  Farmers  Branch,  TX)  for 
lumbar levels; a 22-gauge spinal needle for sacral levels; 
and  the  caudal  epidural space  with  an  18-gauge Tuohy 
needle through the sacral hiatus. Lumbar interlaminar in-
j e c t i o n s  u s e d  t h e  l o s s  o f  r e s i s t a n c e  t e c h n i q u e  w i t h  a n 
18-gauge Tuohy needle followed by confirmation by con-
trast medium injection. 
5. Objectives
The objective of this assessment was to evaluate and 
compare the efficacy of 3 lumbar epidural injection ap-
proaches using local anesthetic alone or local anesthetic 
with steroid for managing chronic low back and lower ex-
tremity pain secondary to disc herniation or radiculitis.14 Korean J Pain Vol. 28, No. 1, 2015
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Fig. 1. Illustration of average Numeric Rating Scale scores
for pain at different follow-up points by type of epidural.
*P value at different time intervals as compared with 
baseline (within group, pair-wise comparisons with Bonferroni
correction) #1 P = 0.058, #2 P = 0.227, #3 P = 0.269, 
#4 P = 0.355, #5 P = 0.202, #6 P = 0.515 respectively,
for between-group comparisons at specified time intervals 
with Bonferroni correction.
6. Outcomes
Patient outcomes were measured at baseline, 3, 6, 12, 
18 and 24 months post-treatment. The outcomes meas-
ured were pain, using the Numeric Rating Scale (NRS) pain 
scale (0-10) [30]; functional assessment using the Oswe-
stry Disability Index (ODI) (0-50 scale) [31]; employment 
s t a t u s ;  o p i o i d  i n t a k e  i n  t e r m s  o f  m o r p h i n e  e q u i v a l e n t s .  
Thresholds for the minimum clinically important difference 
for ODI varied from a 4 to 15 point change from a total 
score of 50 and more recently, higher minimal improve-
ments [14-16]. 
7. Sample size
The sample size determination was based on previous 
assessments. Sample size calculation required a total of 
110 patients with 55 patients in each group for each trial 
considering a 0.05, 2-sided significance level, with a pow-
er of 80%, and an allocation ratio of 1:1. Consequently, for 
the 3 trials, 120 patients were included in each trial.
8. Sequence generation
Randomization was performed by computer-generated 
random allocations sequence by simple randomization. 
9. Allocation concealment
The operating room nurse assisting with the procedure 
randomized the patients and prepared the drugs appro-
priately. 
10. Blinding (Masking)
Group assignments were blinded to both the study pa-
t i e n t s  a n d  t h e  m e d i c a l  p e r s o n n e l  w h o  a d m i n i s t e r e d  t h e 
in terv en tions. The injectates used f or bo th gr o u ps w er e 
clear and indistinguishable from each other or covered to 
avoid identification. 
11. Statistical analysis 
For the present analysis, the Statistical Package for 
Social Sciences version 9.01 (SPSS Inc, Chicago, IL) was 
utilized. For categorical and continuous data comparison, 
Chi-square (Fisher test where necessary) and t test were 
used respectively. Because the outcome measures of the 
participants were measured at 6 points in time, repeated 
measures analysis of variance were performed with post 
hoc analysis with Bonferroni correction. A P value of less 
than 0.05 was considered significant. 
An intent-to-treat analysis, which was performed af-
ter the sensitivity analysis in the original trials, was carried 
forward. 
RESULTS
1. Patient flow
Patient  flow  was  shown  in  Fig.  1  of  each  of  the  3 
manuscripts  [14-16].  As  described  in  these  manuscripts 
[14-16], follow-up was available for 80%, 84%, and 83% 
of patients in caudal, interlaminar, and transforaminal tri-
als respectively at the end of 2 years. 
2. Recruitment 
The trial recruitment period lasted from January 2007 
t h r o u g h  O c t o b e r  2 0 0 9  f o r  c a u d a l  e p i d u r a l  i n j e c t i o n s ,  
January 2008 through May 2010 for interlaminar epidural 
injections, and January 2010 through December 2011 for 
transforaminal epidural injections. 
3. Baseline characteristics
Table  1  shows the baseline demographic and clinical 
characteristics of each trial.
There were significant differences noted in the base-
lin e c h ar a c teris ti cs am o ng th e 3 t ria ls, f o r gen d er dis-Manchikanti, et al / Comparison of Epidurals in Lumbar Disc Herniation 15
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Table 1. Baseline Demographic and Clinical Characteristics
Caudal
(120)
Interlaminar
(120)
Transforaminal 
(120)
P value
Gender
Age
Weight
Height
Body mass index 
Duration of pain (months)
Onset of pain
Numeric rating scale 
Oswestry disability index
Disc herniation* (levels)
Male
Female
Mean ± SD
Mean ± SD
Mean ± SD
Mean ± SD
Mean ± SD
Gradual
Sudden onset with incident 
 (work injury, motor vehicle 
 accident, etc.)
Mean ± SD
Mean ± SD
L3/4
L4/5
L5/S1
35% (42)
65% (78)
45.9 ± 14.5
192.9 ± 52.6
66.4 ± 3.8
30.7 ± 8.1
87.3 ± 84.2
88.8% (74)
11.2% (46)
7. 9 ± 1.0
28.6 ± 4.7
6.7% (8)
68.3% (82)
54.2% (65)
50% (60)
50% (60)
44.8 ± 13.9
190.3 ± 49.1
67.1 ± 4.2
29.8 ± 7.4
134.1 ± 114.0
66.7% (80)
33.3% (40)
8.1 ± 0.9
30.0 ± 4.8
20% (24)
63% (76)
56% (67)
31% (37)
69% (83)
42.8 ± 11.4
188.5 ± 50.4
65.7 ± 3.6
30.6 ± 7.7
101.1 ± 87.8
78.3% (94)
21.7% (26)
8.2 ± 0.9
29.0 ± 5.1
5.0% (6)
49.2% (59)
68.3% (82)
0.006
0.210
0.799
0.019
0.564
0.001
0.012
0.058
0.052
NA
*Multiple patients presented with a disc herniation at more than one level.
Table 2. Comparison of Numeric Rating Scale Scores for Pain and Oswestry Disability Index Scores for Function at 2 Years
Numeric rating scale scores for pain Oswestry disability index scores for function
Caudal Interlaminar Transforaminal Caudal Interlaminar Transforaminal
Baseline 
3 months 
6 months 
12 months 
18 months
24 months 
Group difference 
Time difference
 7.9 ± 1.0
3.7* ± 1.8
(78%)
3.7* ± 1.7
(79%)
3.8* ± 1.8
(73%)
3.8* ± 1.8
(70%)
3.9* ± 1.8
(66%)
 8.1 ± 0.9
3.7* ± 1.3
(83%)
3.8* ± 1.4
(79%)
3.7* ± 1.4
(79%)
3.7* ± 1.6
(73%)
3.9* ± 1.5
(67%)
0.724
0.001
 8.2 ± 0.9
4.0* ± 1.6
(75%)
4.0* ± 1.6
(71%)
4.0* ± 1.6
(70%)
4.1* ± 1.6
(66%)
4.1* ± 1.6
(63%)
 28.6 ± 4.7
15.0* ± 6.9
(68%)
14.6* ± 7.1
(73%)
14.2* ± 7.1
(71%)
14.3* ± 7.1
(69%)
14.6* ± 7.3
(65%)
 30.0 ± 4.8
14.9* ± 5.4
(78%)
14.8* ± 5.6
(76%)
14.4* ± 5.8
(78%)
14.5* ± 6.5
(73%)
14.8* ± 6.0
(68%)
0.308
0.001
 29.0 ± 5.1
15.6* ± 6.8
(72%)
14.8* ± 6.6
(73%)
14.6* ± 6.7
(69%)
14.5* ± 6.7
(70%)
14.5* ± 6.7
(68%)
A lower value indicates better condition. *Significant difference with baseline values within the group (P < 0.001). Illustrates proportion 
with significant pain relief (≥ 50%) from baseline.
tribution, height, and duration of pain. Disc herniations in 
some patients were present at more than one level. Disc 
herniation at L5/S1 were 54% in the caudal trial, 56% in 
interlaminar trial and 68% in the transforaminal trial.
4. Analysis of outcomes
Pain relief and functional assessment: As shown in 
Table 2 and Fig. 1, 2, repeated measures ANOVA revealed 
time × factor (P ＜ 0.001 for both NRS and ODI); however, 
among the 3 groups the effect was not found to be sig-
nificant (P ＞ 0.3 for VAS and ODI). Follow-up within a 
group pair-wise analysis revealed that NRS and ODI de-
creased significantly in all time intervals compared with 
baseline in the 3 groups (Table 2). A between-group analy-
sis revealed that NRS and ODI scores were comparable in 
the 3 groups at all time intervals.16 Korean J Pain Vol. 28, No. 1, 2015
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Fig. 2. Illustration of average Oswestry Disability Index 
scores for function at different follow-up points by type of
epidural. *P value at different time intervals as compared 
with baseline (within group, pair-wise comparisons with 
Bonferroni correction) #1 P = 0.052, #2 P = 0.652, #3
P = 0.951, #4 P = 0.896, #5 P = 0.963, #6 P = 0.925
respectively, for between-group comparisons at specified 
time intervals with Bonferroni correction.
Fig. 5. Illustration of reduction (at least 50%) of Numeric 
Rating Scale scores for pain and Oswestry Disability Index
scores for function from baseline (all patients).
Fig. 3. Illustration of reduction (at least 50%) of Numeric 
Rating Scale scores for pain and Oswestry Disability Index
scores for function from baseline (all patients).
Fig. 6. Illustration of reduction (at least 50%) of Numeric 
Rating Scale scores for pain and Oswestry Disability Index
scores for function from baseline (only responsive patients).
Fig. 4. Illustration of reduction (at least 50%) of Numeric 
Rating Scale scores for Pain and Oswestry Disability Index
scores for function from baseline (only responsive patients).
As shown in Fig. 3, 4, significant improvement was de-
fined as 50% or more improvement in pain relief and func-
tional status assessment. There was significant difference 
between interlaminar, and transforaminal at 12 months for 
steroid group (Fig. 3). There were no significant differences 
between groups (caudal, interlaminar, and transforaminal) 
at any of the time points as shown in Fig. 4. As shown 
in Fig. 5, significant pain relief at 12 months was 69%, 77% 
and 66%, and at 24 months was 63%, 65% and 61 for cau-Manchikanti, et al / Comparison of Epidurals in Lumbar Disc Herniation 17
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Table 3. Therapeutic Procedural Characteristics with Procedural Frequency, Average Relief per Procedure, and Average Total Relief in Weeks
Over a Period of 2-Years
Responsive patients  Nonresponsive patients All patients
Caudal
(97)
Interlaminar 
(109)
Transforaminal
(94)
Caudal
(23)
Interlaminar
 (11)
Transforaminal
(26)
Caudal
(120)
Interlaminar 
(120)
Transforaminal
(120)
Average number of 
procedures for one year
Average number of 
procedures for two years
Average relief for 
first procedure
Average relief for 
second procedure
After initial 2 procedures
Average relief per 
procedure
Average total relief for 
one year (wks)
Average total relief for 
two year (wks)
 4.0 ± 1.0
 6.1 ± 2.3
 5.9 ± 4.9
12.1* ± 14.2
(97)
13.5 ± 6.8
(399)
12.0 ± 8.7
 41.7 ± 11.2
 73.4 ± 29.3
 4.0 ± 1.1
 6.1 ± 2.4
 6.2 ± 8.6
 8.3 ± 4.1
(107)
13.8 ± 6.5
(444)
11.7 ± 7.3
 41.3 ± 14.8
 70.2 ± 29.9
4.0 ± 1.1
5.8 ± 2.4
4.7 ± 7.1
8.3 ± 4.8
(91)
14.3 ± 6.9
(361)
11.6 ± 7.7
39.1 ± 13.3
67.1 ± 31.0
2.3 ± 1.2
2.3 ± 1.3
1.6 ± 2.2
0.9 ± 2.6
(18)
6.2 ± 7.6
(13)
2.5 ± 4.7
5.7 ± 8.5
5.8 ± 9.2
2.0 ± 0.6
2.0 ± 0.6
0.9 ± .8
0.2 ± 0.4
(9)
0.5 ± 0.7
(2)
0.6 ± 0.7
1.2 ± 1.1
1.2 ± 1.1
2.0 ± 0.9
2.1 ± 1.6
1.3 ± 1.6
1.1 ± 1.4
(18)
7.7 ± 6.2
(11)
2.5 ± 4.0
3.2 ± 5.2
 5.3 ± 15.4
3.7 ± 1.3
5.4 ± 2.6
5.1 ± 4.8
(120)
10.4* ± 13.7
(115)
13.3 ± 7.0
(412)
11.2 ± 8.8
34.8 ± 17.8
60.5 ± 37.7
3.8 ± 1.2
5.7 ± 2.5
5.7 ± 8.3
(120)
7.7 ± 4.5
(116)
13.8 ± 6.5
(446)
11.3 ± 7.4
37.6 ± 18.3
63.9 ± 34.8
3.5 ± 1.4
5.0 ± 2.7
3.9 ± 6.4
(120)
7.1 ± 5.1
(109)
14.1 ± 7.0
(372)
10.8 ± 7.8
31.3
# ± 19.1
53.7 ± 38
*Significant difference with interlaminar & transforaminal, 
#Significant difference with interlaminar.
dal, interlaminar and transforaminal epidurals respectively. 
Significant pain relief was comparable among the 3 groups 
at all follow-up points. Fig. 6 shows significant improve-
ment for responsive patients only, with 76%, 72% and 77% 
at 24 months for caudal, interlaminar and transforaminal 
epidurals respectively; there was no significant difference 
among the 3 groups.
5. Therapeutic procedural characteristics
Therapeutic procedural characteristics for a period of 
2 years for all 3 trials are shown in Table 3. The results 
showed 5 to 6 procedures over a period of 2 years with 
average relief for the first procedure of 4 to 6 weeks, with 
average relief for the second procedure of 7 to 12 weeks, 
and 13 to 14 weeks of average relief for the therapeutic 
phase after the first 2 procedures, per procedure. Average 
total relief for 2 years ranged from 67.1 ± 31 weeks in 
the transforaminal group, 70.2 ± 29.9 weeks in the inter-
laminar group, and 73.4 ± 29.3 weeks in the caudal group 
in responsive patients; whereas the average total relief of 
2 years in all patients was 53.7 ± 38 weeks in the trans-
foraminal group, 60.5 ± 37.7 weeks in the caudal group, 
and 63.9 ± 34.8 weeks in the interlaminar group. 
6. Covariates of gender, duration of pain and onset of the 
pain
Univariate analyses of variance with gender, duration 
of pain, and onset of the pain as a covariate revealed no 
significant  differences  in  average  pain  and  ODI  scores 
among three groups.
7. Adverse events
There were no major adverse events in any of the 3 
trials. 
DISCUSSION
In the management of chronic, persistent low back and 
lower extremity pain secondary to disc herniation and rad-
iculitis, the present assessment comparing caudal, inter-
l a m i n a r ,  a n d  t r a n s f o r a m i n a l  a p p r o a c h e s  t o  e p i d u r a l  i n-
jections in 3 large trials of 120 patients in each trial re-
c e i v i n g  e i t h e r  l o c a l  a n e s t h e t i c  a l o n e  o r  l o c a l  a n e s t h e t i c 
with steroid with 60 patients in each group showed a lack 
of superiority for any of the approaches. A similar pro-
portion of patients showed significant improvement in the 
3 trials: 77% with caudal, 72% with interlaminar, and 80% 
with transforaminal approaches receiving local anesthetic 18 Korean J Pain Vol. 28, No. 1, 2015
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a lone, and 76% with caudal, 71% with in terlaminar, and 
73% with transforaminal with local anesthetic and steroid 
at 2 years. The number of procedures and the average re-
lief for 2 years was also similar in all trials with local anes-
thetic alone or local anesthetic with steroid. 
The analysis of caudal epidural injections of local an-
esthetic with steroid [14] showed the potential superiority 
for the addition of steroid compared with local anesthetic 
alone at 2-year follow-up based on the average relief per 
procedure. In addition, the lumbar interlaminar epidural in-
jections trial [15] showed the potential superiority of local 
anesthetic  with  steroid  for  pain  relief  at  6  months  and 
f u n c t i o n a l  s t a t u s  a t  1 2  m o n t h s .  F u r t h e r m o r e ,  t h e  n o n-
responsive rate was significantly lower in the interlaminar 
group, 9% versus 19% in the caudal group and 22% in the 
transforaminal group. Consequently, it appears that pa-
tients in the interlaminar group who received steroid re-
sponded better, with only one nonresponsive patient com-
pared to caudal epidural injections with steroids. 
There was also no significant difference based on the 
levels of disc herniation. Based on the SPORT assessment 
of L4-5 disc herniations in 38%, one would expect superi-
ority with lumbar interlaminar and transforaminal consid-
ering  a  targeted  delivery  rather  than  a  large  volume 
reaching the target site with caudal [3]. Disc herniations 
were noted at L4-5 in a significantly high proportion of 
patients in the caudal trial (68%) compared to interlaminar 
(80%) and transforaminal (50%) trials. One could postulate 
that L5-S1 disc herniation may respond well to a caudal 
epidural, but not L4-L5. This study shows otherwise, in 
that there were a larger proportion of patients with L4-L5 
disc herniation in the caudal group than in the interlaminar 
group. Based on the lumbar interlaminar group, it appears 
that patients who were nonresponsive to epidural injections 
with local anesthetic alone may respond with the addition 
of a steroid. Thus, this assessment, based on the data 
from 3 large randomized trials, provides evidence that, in 
carefully selected patients, with repeat injections in con-
temporary interventional pain management settings under 
fluoroscopy,  patients  respond  to  both  local  anesthetic 
alone and local anesthetic with steroid in all 3 approaches 
in a similar fashion. Based on the frequency of epidural 
injections and the duration of relief, it appears that sig-
nificant improvement lasts approximately 13 or 14 weeks. 
Consequently, it has been shown that over a period of 2 
years, for multiple etiologies, approximately 6 epidural in-
jections have been utilized in the group responsive to initial 
2 procedures with at least 3 weeks of relief [14-16].
In the past, based on blind interlaminar trials, the evi-
dence appeared to favor caudal epidural injections, where-
as more recently it has been in favor of transforaminal 
epidural injections [8,10]. Now it appears, however, that 
based on large randomized controlled trials the evidence 
is the same for all 3 approaches. This assessment of trials 
performed with proper methodology in a practical setting 
provides appropriate information and facilitates the proper 
application of interventions to reduce a patient’s pain, 
improve function, reduce drug use, and potentially return 
the  patient  to  the  work  force.  However,  inappropriate 
pr ov i s i o n  o f  a n y  t y p e  o f  i n t e r v e n t i o n ,  s p e c i f i c a l l y  t h o s e 
that are  not cost-effective,  incurs  substantial expenses 
[6-8,13,17,32-34].  Blinding  would  have  been  extremely 
difficult in one trial. Further, there was no placebo group 
in any of the trials. Systematic reviews undertaken without 
the proper utilization of criteria will ultimately be detri-
mental to both the patient and the economy of health care. 
There has been only one randomized controlled trial, 
published by Ackerman and Ahmad [35], comparing caudal, 
interlaminar, and transforaminal approaches. This assess-
ment showed the superiority for transforaminal over inter-
laminar and caudal, and interlaminar over caudal; however, 
the follow-up was for only 6 months and the trial was not 
of high quality [9-11,13]. 
I n  t h e  e r a  o f  e v i d e n c e - b a s e d  m e d i c i n e  a n d  c o m -
parative effectiveness research, practical clinical trials with 
a pragmatic approach are considered to be clinically appli-
cable and valid [7-11,17,32-34,36,37]. The trials utilized in 
this  assessment  met  the  essential  criteria  for  practical 
clinical trials, with a measurement of effectiveness, rather 
than efficacy, which is considered to be more clinically ap-
plicable, resulting in practical implications and applications 
for interventional pain management providers [36,37]. 
This assessment may be criticized for multiple defi-
ciencies, including the 3 separate randomized trials utilized 
in this analysis. The major deficiency of this assessment 
may be that these trials were conducted separately rather 
than as one trial; however, blinding would have been ex-
tremely difficult. There were no placebo groups in any of 
the trials. Placebo design and placebo use in interventional 
techniques continues to be widely debated. A placebo de-
sign for interventional techniques has been criticized for 
its inappropriate utilization in assessing epidural injections Manchikanti, et al / Comparison of Epidurals in Lumbar Disc Herniation 19
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including  caudal,  interlaminar,  and  transforaminal  ap-
proaches [7-11,38-41]. In addition, all the placebo-con-
trolled trials in the interlaminar approach were in blind epi-
dural groups with significant variability [42-44]. Two of 
these trials utilized an injection of sodium chloride solution 
into the interspinous ligament and compared that with epi-
dural steroid injections [42,43]. One study was performed 
in 1973 [43] and other one was performed in 2005 [42]. 
These 2 studies reached different conclusions. One study 
commonly cited in systematic reviews and health policies 
that has obtained substantial publicity was published in the 
New England Journal of Medicine [44]. It utilized epidural 
saline versus steroid. In reference to caudal epidural, the 
only study with a placebo design was by Iversen et al. [40]. 
This study has been criticized for its inappropriate meth-
odology and flawed conclusions. Recently, proper placebo 
design has been lauded for its use in transforaminal epi-
dural  injections  and  percutaneous  adhesiolysis  [38,41]. 
These  properly  conducted  trials  showed  the  appropriate 
effect of sodium chloride solution with injection into an in-
active structure(s). Thus, the systematic reviews and opin-
ions which equate local anesthetic with placebo are not 
only  methodologically  and  conceptually  inaccurate,  but 
they also result in improper conclusions [12,32-34,40]. The 
role of placebo and appropriate interpretations of placebo 
have been extensively discussed [45-47]. Further, ample 
evidence has proved that inactive substances, when in-
jected in to acti v e stru ctur es, in v aria bly r esult in v arious 
types of clinical effects [8-16,21-28,47-49]. The injection 
of sodium chloride solution into an epidural space has been 
shown to be clinically effective in multiple studies [8,47]. 
Furthermore, local anesthetics also have shown long-term 
improvement or response equal to steroids in clinical and 
experimental settings [8-16,21-28]. Thus, it is imperative 
in interventional pain management to design a proper pla-
cebo study, with injection of inactive solutions into inactive 
structures. Further, it is also important to assess not only 
the differences among the 3 techniques, and the solutions 
injected, but also to extend the assessment at baseline to 
follow-up periods rather than depending on between the 
group or between the trial differences. 
Epidural steroids in disc herniation and radiculitis are 
provided based on the pathophysiologic mechanism of in-
flammation [8-16,21-28]. Consequently, epidural steroids 
have been recommended as effective in disc herniation and 
radiculitis secondary to their antiinflammatory properties. 
However, emerging evidence also shows that local anes-
thetics with or without steroids are as equally effective as 
steroids in many settings [8-16,21-28]. 
The results of a 2 year f ollow-up of 3 rand omized, 
double-blind, controlled trials, with a total of 360 patients 
with chronic persistent pain of disc herniation receiving ei-
ther caudal, lumbar interlaminar or transforaminal epidural 
injections, showed similar efficacy of the 3 techniques with 
l o c a l  a n e s t h e t i c  a l o n e  o r  l o c a l  a n e s t h e t i c  w i t h  s t e r o i d .  
C a u d a l  a n d  i n t e r l a m i n a r  t r i a l s  u s e d  i n  t h i s  a s s e s s m e n t  
have shown some superiority of steroids over local anes-
thetic, at 3 and 6 month follow-up. Interlaminar with ste-
roids were superior to transforaminal at 12-months.
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